Shares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billion in punitive damages to a man who accused the drugmaker of failing to warn that young men using its antipsychotic drug Risperdal could grow breasts.
from Reuters: Health News https://ift.tt/2pX5pOZ
No comments:
Post a Comment